EP2950795
Aðferð til að meðhöndla og lækna Leishmaníu-veiki með því að nota fexinídasól
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
31.1.2014EP published:
25.4.2018EP application number:
14705908.3
EP translation filed:
13.7.2018Grant published:
15.8.2018EPO information:
European Patent Register
Max expiry date:
30.1.2034Expiry date:
30.1.2027Next due date:
31.1.2027
Title:
METHOD FOR TREATING AND CURING LEISHMANIOSIS USING FEXININDAZOLE
Timeline
Today
31.1.2014EP application
25.4.2018EP Publication
13.7.2018Translation submitted
15.8.2018Registration published
30.1.2027Expires
Owner
Name:
Boehringer Ingelheim Animal Health USA Inc.Address:
3239 Satellite Boulevard, Bldg. 500, 30096, Duluth, GA, US
Inventor
Name:
POLLMEIER, MatthiasAddress:
Düsseldorf, FR
Name:
BLAIR, Jeffrey, JynnAddress:
Bordeaux, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361758918 PDate:
31.1.2013Country:
US
Classification
Categories:
A61K 31/4164, A61P 33/02
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 2.1.2019
Expires: 30.1.2020
Payer: Sigurjónsson & Thor ehf.
Number: 7
Paid: 3.1.2020
Expires: 30.1.2021
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 31.12.2020
Expires: 30.1.2022
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 12.1.2022
Expires: 30.1.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 10
Paid: 10.1.2023
Expires: 30.1.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 11
Paid: 10.1.2024
Expires: 30.1.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 12
Paid: 13.1.2025
Expires: 30.1.2026
Payer: G.H. Sigurgeirsson ehf.
Number: 13
Paid: 12.1.2026
Expires: 30.1.2027
Payer: G.H. Sigurgeirsson ehf.